Today: 28 June 2026
Browse Category

SWX:NOVN 26 September 2025 - 7 February 2026

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.
7 February 2026
···
Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis shares closed up nearly 1% at 115.60 francs in Zurich after U.S. regulators granted Breakthrough Therapy status to its Sjögren’s disease drug candidate, ianalumab. The Swiss Market Index fell 0.47%. Novartis plans global submissions for ianalumab in early 2026. U.S. markets will be closed Monday for Martin Luther King Jr. Day.
18 January 2026
··
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, 21 November 2025: SMI Holds Near Flat as Tech Slides and Defensives Lift Zurich

The Swiss Market Index erased early losses to trade 0.08% higher at 12,553 points by mid-morning Friday, as investors shifted from tech to defensive blue chips. UBS shares fell after a $3 billion buyback, while SGS rose on an acquisition. Nestlé digested a top executive’s retirement, and Schindler’s HR chief exited abruptly. The STOXX 600 dropped 1% amid global tech sell-offs and Fed uncertainty.
21 November 2025
······
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

European stocks hit three-week lows Thursday, then rebounded Friday as the STOXX 600 fell 0.7% before rising 0.3%. U.S. President Trump’s new tariffs on drugs and trucks triggered a 2% drop in major pharma and truck stocks. The Bank of England warned on persistent UK inflation, while the ECB and Swiss National Bank held rates steady. Germany’s consumer confidence improved; Spain’s GDP beat forecasts.
26 September 2025
········

Stock Market Today

  • GM Stock Doubles in 3 Years: 3 Reasons for Continued Growth
    June 28, 2026, 5:18 PM EDT. General Motors (GM) stock has surged 116% over three years, outperforming the S&P 500. Key drivers include GM's substantial share buybacks reducing outstanding shares by 500 million, boosting shareholder value. GM's OnStar and Super Cruise software subscriptions deliver high-margin, recurring revenue of over $2.7 billion realized and $5.4 billion deferred. The company anticipates further growth this year, with expected revenues of $3.1 billion realized and $7.5 billion deferred from these services. GM aims to achieve profitability in electric vehicles within three to five years, supported by strong cash flow from truck and SUV sales. Investors who overlooked GM's rise may find value in its robust buyback strategy, expanding software businesses, and EV prospects, positioning the stock for continued gains.

Latest articles

Nu Holdings shares finish up for the week after Needham call

Nu Holdings shares finish up for the week after Needham call

28 June 2026
Nu Holdings (NYSE:NU) surged 5.7% to $13.17 Friday, flipping its week to a 3.6% gain and outperforming both the iShares MSCI Brazil ETF and the Nasdaq, after Needham initiated coverage with a $17 price target, citing a “scaled and profitable customer base” and expected U.S. expansion within a year.
Go toTop